Medscape Medical NewsAll articles

aiCockpit AI Viewer

Fovia, Inc. • Radiology • 02/26/2025

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

The Fovia, Inc. aiCockpit AI Viewer is a medical image management and processing system designed to enhance clinical review by integrating artificial intelligence software with advanced 3D rendering capabilities. It functions as an overlay on DICOM images, providing annotations and measurements, thereby aiding clinicians in reviewing findings by presenting imaging data alongside clinical documents.

Summary

On February 26, 2025, a determination was issued regarding Fovia, Inc.'s aiCockpit AI Viewer, confirming it is substantially equivalent to legally marketed products. This device is a medical image management and processing system designed for clinical review in General Radiology and other healthcare imaging applications. It functions as software that displays annotations and measurements as an overlay on images from DICOM objects and artificial intelligence software. The viewer also supports 3D Multi-Planar Reformatting, 3D Maximum Intensity Projection, and 3D Volume Rendering, and aids in reviewing findings by presenting clinical documents and reports alongside images. It is intended for use with off-the-shelf computing devices and supports major desktop browsers.Companies marketing such devices must adhere to ongoing regulatory requirements, including annual registration, device listing, good manufacturing practices, and specific labeling rules. The determination of equivalence does not imply compliance with all other federal statutes, and manufacturers must also comply with quality system regulations, covering aspects like design controls and corrective actions. Additionally, the aiCockpit AI Viewer is subject to Unique Device Identification System regulations, requiring specific labeling and database submissions. Resources are available for information on changes that may require further review, adverse event reporting, and comprehensive regulatory assistance.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

FoviaInc.aiCockpit AI ViewerMedical image managementDICOMArtificial intelligence software3D renderingRegulatory requirementsSubstantial equivalenceClinical reviewQuality system regulations

Device Metadata

Submission Number
K241546
Company
Fovia, Inc.
Panel
Radiology
Product Code
N/A
Data Type
N/A
Clinical Function
N/A
AI Function
N/A
AI Subclass
N/A

Relevant Clinical Questions

  • Q1. How does the aiCockpit AI Viewer's AI software integrate with existing clinical workflows and what specific diagnostic improvements does it offer over traditional image viewers?; What are the performance metrics (e.g., accuracy, speed, latency) of the AI annotations and measurements displayed by the viewer, particularly in diverse clinical scenarios?; Beyond General Radiology, what other specific healthcare imaging applications is the aiCockpit AI Viewer optimized for, and are there any ongoing clinical trials supporting its efficacy in these areas?; What cybersecurity measures are in place to protect patient data and DICOM objects when using the aiCockpit AI Viewer with off-the-shelf computing devices and web browsers?; Given its substantial equivalence, what post-market surveillance data is required or being collected to monitor the long-term performance and safety of the aiCockpit AI Viewer in clinical use?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Post-§524B but no clear network capability detected

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score40/100
SBOM Evidence⚠ Not in summary - likely in full submission per §524B
Cyber Risk Assessment✓ Detected in Summary
Postmarket Plan✓ Detected in Summary
§524B ApplicableYes

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(annotation, labeling)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials
- Not detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM detected in AI-generated device summary.

• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.

• Not detected in AI-generated device summary: SBOM, SaaSBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
aiCockpit AI Viewer - Fovia, Inc. | ESL FDA AI Device Intelligence